ArticleAmerican journal of translational research2026
Case report of durable responders to sintilimab plus second-line chemotherapy in relapsed/refractory angioimmunoblastic T-cell lymphoma.
Wensi Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.